China Approves Wellmune Beta Glucan for Foods
The Ministry of Health in China has approved the immune-supporting ingredient as a novel food ingredient.
The Ministry of Health in China has approved Wellmune WGP beta-glucan as a novel food ingredient, according to the ingredient’s developer, Biothera (Eagan, MN).
Wellmune WGP is a complex carbohydrate derived from the cell walls of the baker’s yeast Saccharomyces cerevisiae. The ingredient supports immune health by stimulating the body’s levels of natural killer cells which detect foreign invaders. Wellmune WGP is supported by a host of in-house human clinical trials that repeatedly demonstrate reduced risk of respiratory tract infections after supplementing with the ingredient.
“We are pleased to have an opportunity to offer our immune health technology to the people of China,” said Richard Mueller, chief executive officer of Biothera. “There are numerous applications in foods and beverages through which Wellmune can support the immune health and overall well-being.”
The company already holds an Asian presence with Sino Biothera HK Ltd., a division that is well-positioned to distribute Biothera products in Hong Kong and China.
Beyond its new Chinese regulatory distinction, the ingredient is non-allergenic, free of genetically-modified organisms (GMOs) and is Generally Recognized as Safe (GRAS) by FDA.
Polyphenols: The next generation of prebiotics is ready for liftoff
April 21st 2025Explore the prebiotic health benefits of polyphenols and the positive impact they may have on digestive and immune health. Polyphenols, such as those found in European black elderberry, may be an ideal solution for manufacturers trying to break into the digestive health space.
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
